A nasal cannula for delivering air to a patient's nares. Two delivery tubes are provided to supply air to a pair of nasal inserts each of which conform to the shape of the nare. Properly placed bleed ports reduce noise and reduce carbon dioxide retained in the system. The cannula is positioned on the face with the aid of a strap system.
|
0. 4. A nasal cannula for use with a constant positive pressure air supply, comprising:
left and right delivery tubes, each tube having a size sufficient to provide all the air required by a patient;
first and second nasal inserts for insertion into a patient's nares, said inserts connected to and extending at an angle relative to respective portions of said tubes;
said nasal inserts each being elongated and comprising a soft, compliant material configured to conform to the cross-section of a nare of a patient when inserted into a nare up to a location where the inner cross-section of the nare equals the outer cross-section of the insert to effect said sealing relationship with the patient's nares; and
two tubular bleed ports, each bleed port having an open internal lumen directly opening into a respective delivery tube and connecting an interior of the delivery tube with an exterior of the delivery tube; and
wherein each bleed port is located directly opposite and aligned with a respective nasal insert, said bleed ports comprising together one of three air exit paths leading away from the nasal inserts.
3. A nasal cannula for use with a constant positive pressure air supply for supplying air (F) between about 10 to 50 liters/minutes, said cannula comprising:
first and second nasal inserts for insertion into a patient's nares; said inserts adapted for a sealing relationship with the patients nares;
a left and right delivery tube coupled to both of said nasal inserts, each of said delivery tubes is sufficient to provide all of the air (F) required by the user,
each nasal insert communicates with both the left delivery tube and right delivery tube;
a coupler located remote from said nasal inserts for coupling said cannula to a source of respiration gas;
at least two bleed ports having an internal lumen directly opening into said delivery tubes connecting the interior of the cannula with the exterior of the cannula;
said bleed port active during exhalation to remove respired air from the cannula;
each of said bleed ports located beneath each of said nasal inserts for preferentially intercepting expired gas during exhalation;
said bleed ports when two in number and they have a separation distance (L) which is approximated by;
where ‘A’ is a constant of proportionality an ‘X’ is the cross sectional area of the delivery tubes.
1. A nasal cannula for use with a constant positive pressure air supply, comprising:
first and second nasal inserts for insertion into a patient's nares;
said inserts adapted for a sealing relationship with the patient's nares;
a left and a right delivery tube, each coupled to both of said nasal inserts, each of said delivery tubes is sufficient to provide all of the air required by the patient;
a coupler located remote from said nasal inserts for coupling said cannula to a source of respiration gas;
two tubular bleed ports having an internal lumen directly opening into said delivery tubes connecting an interior of the cannula with an exterior of the cannula;
each of said bleed ports having a characteristic area expressed as a bleed port diameter called BPD, and separated by a distance called L;
each of said tubular bleed ports located beneath each of said nasal inserts such that a first bleed port is located beneath a first insert and a second bleed port is located beneath a second insert, for preferentially intercepting expired gas during exhalation;
the sum total of said bleed port diameters, called the Total Bleed Port diameter (TBPD), have a T BPD/L ratio of between 0.1 and 0.5 such that for the two bleed ports: 0.5>2*BPD/L>0.1
2. A nasal cannula for use with a constant positive pressure air supply, supplying air (F) at between about 10 to 50 liters/minutes, said cannula comprising:
first and second nasal inserts for insertion into a patient's nares;
said inserts adapted for a sealing relationship with the patients nares;
a left and right delivery tube coupled to both of said nasal inserts, each of said delivery tubes is sufficient to provide all of the air (F) required by the user;
each nasal insert communicates with both the left delivery tube and right delivery tube;
a coupler located remote from said nasal inserts for coupling said cannula to a source of respiration air;
at least two bleed ports having an internal lumen directly opening into said delivery tubes connecting the interior of the cannula with the exterior of the cannula;
said bleed port active during exhalation to remove respired air from the cannula;
each of said bleed ports located beneath each of said nasal inserts for preferentially intercepting expired gas during exhalation;
each of said bleed ports has an individual diameter size (BPD) which is approximated by
where IDS is the immediate dead space volume of the delivery tubes proximate the nares, and ‘X’ is the cross section area of the cylinder volume of the delivery tubes between said bleed ports.
0. 5. The nasal cannula as claimed in claim 4, including a soft flange located at a distal terminal end of each nasal insert, each flange readily conformable with a patient's nare and enabling a sealing with the interior of a nare in which the insert is placed when the insert is inserted up to a location where the cross-section of the flange equals the cross-section of the nare.
0. 6. The nasal cannula as claimed in claim 5, wherein said left and right delivery tubes include portions adjacent to the nasal inserts, wherein said delivery tube portions adjacent to the nasal inserts, the nasal inserts and the flanges are made in one integral piece.
0. 7. The nasal cannula as claimed in claim 6, wherein said delivery tube portions adjacent the nasal inserts, the nasal inserts and the flanges are made of silicone rubber.
0. 8. The nasal cannula as claimed in claim 4, further comprising a coupler located remote from said nasal inserts for enabling coupling said delivery tubes to a source of respiration gas.
0. 9. The nasal cannula as claimed in claim 4, wherein each bleed port extends inwardly of an inner wall of a respective delivery tube, and comprises a bleed tube that extends toward a respective nasal insert.
0. 10. The nasal cannula as claimed in claim 4, wherein said delivery tubes include portions generally aligned adjacent to the nasal inserts so as to feed pressurized air towards a central area between the delivery tubes beneath the nasal inserts, and wherein each bleed port comprises a bleed tube extending into the interior of a respective delivery tube from an inner wall thereof in a direction generally normal to the direction of motion of the air supply flowing in the respective delivery tube, each bleed tube further extending toward and parallel with a respective nasal insert.
0. 11. The nasal cannula as claimed in claim 10, each bleed tube terminating at a location spaced inwardly from an inner wall of a respective delivery tube and directly opposite an inner end of a respective nasal insert at its juncture with a delivery tube.
0. 12. The nasal cannula as claimed in claim 11, wherein each delivery tube has a wall thickness, and each bleed tube has a characteristic height that is at least twice and less than 10 times the wall thickness of a respective delivery tube at the location of the bleed tube.
0. 13. The nasal cannula as claimed in claim 10, wherein the bleed tube has a tapered outer shape, tapering inwardly from the respective delivery tube inner wall towards each nasal insert.
0. 14. The nasal cannula as claimed in claim 10, wherein the cannula, including nasal inserts, bleed tubes, and at least part of the delivery tubes adjacent to the nasal inserts, are made in a single unitary and integral piece.
0. 15. The nasal cannula as claimed in claim 14, wherein the cannula, including said nasal inserts, bleed tubes and said at least part of the delivery tubes adjacent to the nasal inserts, are made of silicone rubber.
|
The present invention relates generally to a nasal mask or cannula and more particularly to a nasal cannula for treating a patient with a positive ventilation pressure machine for assisted ventilation.
Positive air pressure (PAP) assisted ventilation systems have been adopted for the treatment of various disorders. PAP systems are commonly used to treatment sleep apnea. Variations of PAP systems have been used to administer drugs and the like.
In operation the patient's respiration is assisted by an external pump which supplies air to the patient under a slight positive pressure. In the conventional system, air is delivered in response to preset conditions selected for each individual patient. In normal operation the patient's inspiratory phase is assisted by a pump which delivers an adequate supply of air at a slight positive pressure to a mask or cannula that is placed on the face of the patient. Full face mask systems which cover both the mouth and the nose are used. Systems which cover the mouth or nose alone are also common.
In use, when the patient exhales, the higher pressure in the mask or cannula system is used to open an exhaust valve. Thus the patient respiration is assisted on the inhalation phase by positive pressure while the expiration phase takes place at approximately atmospheric pressure.
In instances where the patient compliance is affected by the comfort of the mask it is now widely accepted that “nose only” cannula devices are preferred. Examples of current devices can be seen in U.S. Pat. No. 5,477,852 to Landis; U.S. Pat. No. 5,533,506 to Wood; U.S. Pat. No. 5,269,296 to Landis; U.S. Pat. No. 5,687,715 to Landis; U.S. Pat. No. 5,724,965 to Handke.
In contrast to prior air nasal masks, the present system includes a pair of nasal inserts which are fed bilaterally from a pair of delivery tubes which includes both a left and a right leg. If the patient occludes one leg on one side of the mask, the complimentary side is sufficient to provide all of the air required by the patient.
Air is introduced into the system through a Y-shaped adapter or coupler. The shape of the coupler cooperates with other elements to minimize noise.
A pair of bleed ports are placed in the cannula body near the patient's nose. These bleed ports reduce the amount of carbon dioxide retained by the system. The two complex ports are placed in the cannula body to reduce noise and to reduce carbon dioxide build up in the system. Example calculations show how the size, shape and location of each of these ports cooperate to reduce the inhaled carbon dioxide concentration.
An additional feature relates directly to the shape of the nasal inserts. The nasal inserts are sufficiently long and compliant that they may be inserted into the nose until they adopt a location where the cross-section of the nare and the cross-section of the insert are essentially equal. The compliance of the material used to manufacturer the device is sufficient to provide an extremely comfortable fit in the nares.
Throughout the figures of the drawing like reference numerals indicate identical structure wherein:
Turning to
In operation, the positive pressure ventilation machine 24 supplies air under pressure to the nasal cannula 10 and releases exhaled air to the atmosphere. Conventional machines have a valve that is overpressure during exhalation to exhaust air. In some instances the system may also warm and humidify the delivered air. In some instances the machines are used to deliver medications.
The left delivery tube and the right delivery tube 20 should lie close to the face of the patient and the coupler 22 should be positioned in the vicinity of the neck as seen in the figure.
Nasal insert 12 and nasal insert 13 are tubes connected to and extending from the delivery tube 20 and delivery tube 21 respectively. The most distal portion of the insert 12 terminates in a flange 26. It is expected that each flange 26 will be quite soft. The flange 26 is designed to readily conform to the patient's nare. In use the patient will direct the inserts into the nose and the inserts 12 and 13 will move in the nare until the inner cross section of the nare matches the outer cross section of the flange. The anatomy of the nose will deform the shape of the insert and its flange to achieve a comfortable seal. It is expected that only one or two sizes will be required to fit a large population as most patients have similarly sized nares.
The bleed port typified by port 16 is a tube extending from the delivery tube 20 into the insert 12. Each tube has a characteristic height or length. These bleed ports serve several functions. If the bleed ports 16 and 17 are appropriately placed and sized they can reduce the accumulation of carbon dioxide. If they are properly configured, sized and located they can also be used to decrease “whistling” or other acoustic effects. One objective of the bleed ports is to decreases the amount of carbon dioxide in the cannula during inhalation to a targeted value between 0.2 to 0.7 percent. A preferred value is below approximately 0.5 percent. Applicant believes that low carbon dioxide concentrations in the system will prevent build up of carbon dioxide in the patient.
Throughout the figures and specification the following definitions obtain:
Example
It is now recognized that simple ventilation systems which retain a large volume of exhaled gas within the air inlet track result in increased carbon dioxide concentration in the patient's blood. An increase in dissolved carbon dioxide results in the acidification of the blood and increases respiration drive and usually increases respiration rate. In the system the dead space of the device is balanced with both the size and location of the bleed port structures to prevent build-up of the concentration of carbon dioxide in the inhaled air. When the size and location of the ports is optimized, a significant reduction in carbon dioxide gas concentration is achieved.
Generally speaking if the bleed ports are to be small, they need to be located near the nasal inserts. This effect is more important if the dead space within the cannula is large. For this reason, it should be recognized that there is a relationship between dead space, bleed port location and size which can cooperate together to provide a nasal cannula with superior performance. Although it appears that the optimized ports are restrictive due to their length and size, it has also been determined that they can be shaped to minimize parasitic acoustic effects such as “whistling” which is exhibited by current generations of current nasal cannula.
Turning to
A first level approximation identifies that for a given bleed port of area (BPD), the separation distance of the bleed ports is inversely related to the square of the cannula cross sectional area (X)(see
where “A” is the constant of proportionality for the expression and may be solved with reference to the given and established relationships.
It should be noted that if the ports are very far apart they need to be large to reach the carbon dioxide reduction goal, but such large bleed ports reduce the pressure in the system by such a large margin that it no longer effectively provides the positive pressure assistance.
Representative prototype devices have been fabricated with a diameter (to match cross sectional area X) of between ⅜ and ⅝ inches and other dimensions may be approximately scaled from
Various modification and additions to the invention may be made without departing from the scope of the invention.
Lee, Jonathan, Wood, Thomas J., Strickland, Roger
Patent | Priority | Assignee | Title |
10046133, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation for providing ventilation support |
10058668, | May 18 2007 | BREATHE TECHNOLOGIES, INC | Methods and devices for sensing respiration and providing ventilation therapy |
10099028, | Aug 16 2010 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices using LOX to provide ventilatory support |
10232136, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation for treating airway obstructions |
10252020, | Oct 01 2008 | BREATHE TECHNOLOGIES, INC | Ventilator with biofeedback monitoring and control for improving patient activity and health |
10265486, | Sep 03 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature |
10695519, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows |
10709864, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube |
10987481, | Jun 28 2016 | REMSleep Holdings Inc. | Sleep apnea nasal pillows device |
11565067, | Aug 09 2013 | Fisher & Paykel Healthcare Limited | Asymmetrical nasal delivery elements and fittings for nasal interfaces |
11707591, | Apr 02 2009 | Breathe Technologies, Inc. | Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube |
11872347, | Mar 15 2013 | Fisher & Paykel Healthcare Limited | Nasal cannula assemblies and related parts |
11906097, | Sep 04 2019 | Smart Power Partners LLC | Ventilation leak component |
8381729, | Jun 18 2003 | BREATHE TECHNOLOGIES, INC | Methods and devices for minimally invasive respiratory support |
8418694, | Aug 11 2003 | BREATHE TECHNOLOGIES, INC | Systems, methods and apparatus for respiratory support of a patient |
8517022, | Aug 19 2008 | JBR HOLDING, L C | Minimally invasive nasal cannula |
8567399, | Sep 26 2007 | BREATHE TECHNOLOGIES, INC | Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy |
8573219, | Aug 18 2003 | BREATHE TECHNOLOGIES, INC | Method and device for non-invasive ventilation with nasal interface |
8677999, | Aug 22 2008 | BREATHE TECHNOLOGIES, INC | Methods and devices for providing mechanical ventilation with an open airway interface |
8770193, | Apr 18 2008 | BREATHE TECHNOLOGIES, INC | Methods and devices for sensing respiration and controlling ventilator functions |
8776793, | Apr 18 2008 | BREATHE TECHNOLOGIES, INC | Methods and devices for sensing respiration and controlling ventilator functions |
8839791, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
8844533, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
8925545, | Sep 26 2007 | BREATHE TECHNOLOGIES, INC | Methods and devices for treating sleep apnea |
8939152, | Sep 30 2010 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for humidifying a respiratory tract |
8955518, | Jun 18 2003 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for improving ventilation in a lung area |
8985099, | May 18 2006 | BREATHE TECHNOLOGIES, INC | Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer |
9038634, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
9038635, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
9132250, | Sep 03 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature |
9138553, | Mar 13 2000 | INNOMED HEALTHSCIENCE, INC | Ventilation interface for sleep apnea therapy |
9180270, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube |
9227034, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation for treating airway obstructions |
9327092, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
9358358, | Sep 30 2010 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for humidifying a respiratory tract |
9415183, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve |
9486602, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve and method of ventilating a patient using the same |
9616194, | Jun 22 2011 | BREATHE TECHNOLOGIES, INC | Ventilation mask with integrated piloted exhalation valve and method of ventilating a patient using the same |
9675774, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space |
9919121, | Mar 13 2000 | INNOMED HEALTHSCIENCE, INC | Ventilation interface for sleep apnea therapy |
9962512, | Apr 02 2009 | BREATHE TECHNOLOGIES, INC | Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature |
D665496, | Dec 06 2011 | GALEMED CORPORATION | Nasal cannula |
D870269, | Sep 14 2016 | Fisher & Paykel Healthcare Limited | Nasal cannula assembly |
Patent | Priority | Assignee | Title |
1362766, | |||
2663297, | |||
4156426, | Aug 11 1977 | Head-mounted oxygen-administration device | |
4367735, | Dec 31 1979 | UNION TRUST COMPANY | Nasal cannula |
4422456, | Sep 08 1981 | City of Hope National Medical Center | Nasal cannula structure |
4915105, | Oct 28 1988 | Miniature respiratory apparatus | |
4919128, | Aug 26 1988 | UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC | Nasal adaptor device and seal |
4996983, | Jan 31 1989 | Inhaler filtration device with housing supportable by spectacle temple | |
5046491, | Mar 27 1990 | Apparatus and method for respired gas collection and analysis | |
5137017, | Apr 13 1989 | Salter Labs | Demand oxygen system |
5165133, | Dec 16 1991 | Socket cleaner | |
5269296, | Oct 29 1991 | Airways Associates | Nasal continuous positive airway pressure apparatus and method |
5335659, | Apr 12 1993 | Datex-Ohmeda, Inc | Nasal septum probe for photoplethysmographic measurements |
5400776, | Jul 09 1993 | Proprietary Technology, Inc. | Apparatus for maintaining a bend in a medical insufflation tube |
5477852, | Oct 29 1991 | Airways Associates | Nasal positive airway pressure apparatus and method |
5513634, | May 06 1994 | GI SUPPLY, INC | Combination integral bite block airway and nasal cannula |
5533506, | Jan 13 1995 | E BARTER SOLUTIONS, INC | Nasal tube assembly |
5682881, | Oct 21 1996 | Nasal CPAP/Cannula and securement apparatus | |
5687715, | Oct 29 1991 | Airways Associates | Nasal positive airway pressure apparatus and method |
5724965, | Jun 06 1995 | RIC Investments, LLC | Nasal mask |
5794619, | Feb 18 1997 | Nasal cannula mounted solely by frictional engagement with the columella | |
5928189, | Apr 22 1997 | Activity responsive therapeutic delivery system | |
6165133, | Nov 17 1995 | New York University | Apparatus and method for monitoring breathing patterns |
6213955, | Oct 08 1998 | NOVASOM, INC | Apparatus and method for breath monitoring |
6298850, | Aug 05 1999 | Nasal cannula assembly and securing device | |
6354293, | Mar 16 1999 | Breathing humidifier | |
6422240, | Jan 28 1999 | ORIDION MEDICAL LTD | Oral/nasal cannula |
6439234, | Apr 03 1998 | Salter Labs | Nasal cannula |
6478026, | Mar 13 1999 | Salter Labs | Nasal ventilation interface |
6478029, | Feb 22 1993 | Hearport, Inc. | Devices and methods for port-access multivessel coronary artery bypass surgery |
6595215, | Mar 13 2000 | Salter Labs | Ventilation interface for sleep apnea therapy |
6679265, | Oct 25 2001 | InnoMed Technologies, Inc | Nasal cannula |
6776162, | Mar 13 2000 | Salter Labs | Ventilation interface for sleep apnea therapy |
6807967, | Mar 13 2000 | Salter Labs | Ventilation interface for sleep apnea therapy |
6863069, | Mar 13 2000 | Salter Labs | Nasal ventilation interface |
6994089, | Mar 13 2000 | Salter Labs | Nasal ventilation interface |
6997177, | Mar 13 1999 | Salter Labs | Ventilation interface for sleep apnea therapy |
6997187, | Sep 10 2003 | Salter Labs | Nasal interface and system including ventilation insert |
7000613, | Sep 10 2003 | Salter Labs | Nasal interface and system including ventilation insert |
7047974, | Oct 25 2001 | Salter Labs | Nasal cannula |
7059328, | Mar 13 2000 | INNOMED TECHNOLOGIS, INC | Ventilation interface for sleep apnea therapy |
7188624, | Mar 13 2000 | Salter Labs | Ventilation interface for sleep apnea therapy |
7191781, | Aug 05 2003 | Salter Labs | Nasal ventilation interface and system |
7234465, | Aug 05 2003 | Salter Labs | Nasal ventilation interface and system |
20020059935, | |||
20020162558, | |||
20040182397, | |||
20050028821, | |||
20050039757, | |||
20050121037, | |||
20050133040, | |||
20050235999, | |||
20050252515, | |||
20070137653, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 19 2006 | InnoMed Technologies, Inc. | (assignment on the face of the patent) | / | |||
Mar 21 2017 | InnoMed Technologies, Inc | Salter Labs | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 043700 | /0450 | |
Aug 22 2019 | Salter Labs | SALTER LABS, LLC | ENTITY CONVERSION | 050334 | /0131 | |
Aug 30 2019 | SALTER LABS, LLC | CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 050634 | /0660 | |
Aug 30 2019 | Ventlab, LLC | CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 050634 | /0660 | |
Jun 16 2021 | SALTER LABS, LLC | MACQUARIE CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 056602 | /0379 | |
Jun 16 2021 | CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | SALTER LABS, LLC FORMERLY KNOWN AS SALTER LABS | RELEASE OF PATENT SECURITY AGREEMENT | 056646 | /0529 | |
Jun 16 2021 | CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | Ventlab, LLC | RELEASE OF PATENT SECURITY AGREEMENT | 056646 | /0529 |
Date | Maintenance Fee Events |
Aug 28 2015 | REM: Maintenance Fee Reminder Mailed. |
Jan 15 2016 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Jan 15 2016 | M2556: 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity. |
Date | Maintenance Schedule |
Oct 18 2014 | 4 years fee payment window open |
Apr 18 2015 | 6 months grace period start (w surcharge) |
Oct 18 2015 | patent expiry (for year 4) |
Oct 18 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 18 2018 | 8 years fee payment window open |
Apr 18 2019 | 6 months grace period start (w surcharge) |
Oct 18 2019 | patent expiry (for year 8) |
Oct 18 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 18 2022 | 12 years fee payment window open |
Apr 18 2023 | 6 months grace period start (w surcharge) |
Oct 18 2023 | patent expiry (for year 12) |
Oct 18 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |